Introduction
============

The world shrimp production for both farmed and captured shrimp is approximately six million tons, with 60% entering the world market. Shrimp has been reported to be the most essentially traded fishery product internationally as it translates to value. Yearly shrimp exports presently value above US \$10 billion, or 16% of total fish product exports ([@B31]). Shrimp makes up 20% of exported fishery products for more than 20 years ([@B13]). Imports of shrimps into developed nations are responsible for about 40% of trade in intra-developed countries, while approximately 60% comes from developing nations. From developing nation exports, 80% goes to developed nations with only 20% left behind ([@B51]). Shrimps are one of the important exported aquaculture products from the tropics.

*Enterococcus* species are found commonly in the gastrointestinal tract of farmed animals and humans. They form an essential population of commensal bacteria encompassed in the functional microbiota ([@B59]). Epidemiological and ecological findings specify that, along with fecal matter, these commensal bacteria are released into environs they colonize easily as a result of their high adaptability. This translates to their disseminated occurrence in water, soil, sewage, fruits, and plants. Through this means, they consequently exist in raw materials of plant and animal origin (meat, vegetables, and milk) ([@B37]). *Enterococcus* spp. occurrence in foods, with ready-to-eat (RTE) food type inclusive, occurs particularly from their adaptability to severe conditions in the environment as it relates to production and storage conditions. The capability of *Enterococcus* species to proliferate in the occurrence of NaCl (5--10%), bile salt (40%), pH range (4.6--9.9), and anaerobic and aerobic conditions, and its capacity to survive for 30 min in a temperature of 63.5°C revealed that they usually account for the lingering microflora in RTE food ([@B101]).

Enterococci have been implicated in serious infections, reduced production in the grow-out ponds and hatchery, and decreased growth rates and feed conversion in surviving individuals, thereby eliciting a negative impact on the complete financial productivity of the business ([@B30]). Most pathogenesis of infectious enterococci comprises series of events such as establishment, adhering to the host's cell structure, tissue invasion, and unspecific resistance defense mechanism ([@B99]). Literature has reported enterococci that expressed virulence phenotypically to express infections severely compared to those that did not express them at all. The elevated mechanism of enterococci as causative agents that cause infections in patients having their immunity compromised has invigorated further investigations to characterize the elements and/or factors that allow bacteria to inhabit the host effectively through the barriers of the immune system causing pathological alterations ([@B16]).

Continuous proliferation in the amount of *Enterococcus* strains that are antimicrobial resistant has been documented ([@B14]). Vancomycin-resistant *Enterococcus* species presently accounts for the foremost opportunistic pathogen in nosocomial environments ([@B79]). As such, an upsurge in literature that concerns the mechanisms of resistance of these bacteria to several antibiotics has occurred. Occurrence of resistance determinants only does not signify strain pathogenesis. Conversely, when in conjunction with the occurrence of virulence potentials, it may result in dangerous strains ([@B42]). This occurs in particular since genes expressing/conveying resistance virulence factors/elements and antibiotics are usually sited on similar or same genetic determinants. Antibiotic resistance plasmids, transposons, and virulence genes with transmissible characteristics have been reported in literature to be transmissible via highly proficient mechanisms of gene transfer ([@B29]).

Enterococci are described as vital hospital-associated pathogens and have thus been reported to withhold lots of virulence potentials considered significantly essential in exacerbating ailments caused by them. *Enterococcus* strains of clinical origin have been described extensively in literature with limited information of the phenotypic virulence factors coupled with its genetic structure from RTE seafood. Furthermore, enterococci have demonstrated intrinsic antimicrobial resistance to numerous antibiotic agents and can adapt to obtain resistance to antimicrobials from the environment ([@B9]). Multiresistance to a diverse class and subclass of antibiotics along with occurrence of virulence potentials strengthens the vital roles of *Enterococcus* species as opportunistic pathogens. Vancomycin-resistant *Enterococcus faecium* have increasingly been reported since the 1980s. Despite the significant number of literature about vancomycin-resistant *Enterococcus* epidemiology, the evolution and dynamics of these microorganisms are yet to be fully understood. [@B34] reported that both plasmids and strains contributed to the persistence and spread of vancomycin resistance among *E. faecium*. Horizontal gene transfer from different clonal lineages (different or same species) results in chimeras with dissimilar host range and stability, thwarting the surveillance of epidemic plasmids.

Outbreaks of *Enterococcus* species from hospital and environmental sources have been reported in literature in recent times ([@B35]; [@B61]; [@B78]; [@B82]; [@B90]; [@B98]) with little or no information on outbreaks of enterococci infection of food origin. However, consumption of RTE food conveying virulence potentials is an important route of transfer ([@B16]). The current study was carried out to characterize antibiotic-resistant and virulent enterococci from RTE seafood.

Materials and Methods {#s1}
=====================

Sample Collection and Isolation
-------------------------------

Seven hundred and twenty RTE shrimp samples were obtained from markets in Delta State, Nigeria. The different markets sampled from Delta State and their respective coordinates coupled with the sampling procedure have been described previously by [@B8]. A total of six different open markets were sampled, with a total of 60 samples from each market within a 12-month sampling duration. Ten shrimp samples were obtained from each market (four sauced, three boiled, and three smoked shrimps) monthly. The total distribution of the different varieties of shrimp sampled in Delta State is as follows: sauced shrimp, *n* = 288; boiled shrimp, *n* = 216; and smoked shrimp, *n* = 216.

Twenty-five grams of each RTE shrimp sample was homogenized in 225 mL of sterile tryptone soy broth (Lancashire, United Kingdom) and incubated overnight at 37°C. A streak plate method was adopted via streaking from the overnight broth cultures on bile esculin agar (Darmstadt, Germany), which were incubated for 24 h at 37°C. Two to three distinct colonies with black hallow characteristics on the bile esculin agar were purified on nutrient agar (Lancashire, United Kingdom) and incubated for 24 h at 37°C. Purified isolates were stored on nutrient agar slants and maintained at 4°C in the refrigerator.

Identification of *Enterococcus* Species
----------------------------------------

Gram-positive cocci were characterized further using the Analytical Profile Index 20E (BioMerieux, Marcy-l'Etoile, France) in accordance with the instructions of the manufacturer. *Enterococcus faecalis* (ATCC 19433) was used as a positive control. Strips were examined accordingly and identification was secured via an API lab plus software (BioMerieux, Marcy l'Etoile, France). Isolates screened using API were thereafter subjected to DNA extraction using the modified boiling method ([@B9]). PCR using genus-specific and species-specific primers in [Table 1](#T1){ref-type="table"} and PCR conditions previously described was used in the identification of the *Enterococcus* species ([@B28]; [@B26]; [@B52]; [@B45]). Positive controls used include *E. faecalis* (ATCC 19433), *E. faecium* (ATCC 19434), *Enterococcus casseliflavus* (ATCC 25788), *Enterococcus durans* (ATCC 19432), *Enterococcus hirae* (ATCC 8043), and *Enterococcus gallinarum* (ATCC 700425). For the negative control, deionized water was used in place of the template for each test procedure. The Peltier-Based Thermal Cycler (MG96Þ/Y, Zhejiang China) was used in the amplification process. Electrophoresis of the PCR amplicons was performed with 1.5% agarose gel (CLS-AG100, Warwickshire, United Kingdom) in 0.5× TAE buffer (40 mM Tris-HCl, pH 8.5, 1 mM EDTA, and 20 mM Na acetate) and allowed to run for 55 min at 100 V. The gels are visualized under a UV transilluminator (EBOX VX5, Vilber Lourmat, France).

###### 

Primers used in the study.

  ----------------------------------------------------------------------------------------------
  Species/gene targeted   Primer sequence                      Amplicon size (bp)   References
  ----------------------- ------------------------------------ -------------------- ------------
  *Enterococcus* spp.     TCA ACC GGG GAG GGT\                 733                  [@B26]
                          ATT ACT AGC GAT TCC GG                                    

  *E. faecalis*           TCA AGT ACA GTT AGT CTT TAT TAG\     941                  [@B28]
                          ACG ATT CAA AGC TAA CTG AAT CAGT                          

  *E. faecium*            TTG AGG CAG ACC AGA TTG ACG\         658                  [@B28]
                          TAT GAC AGC GAC TCC GAT TCC                               

  *E. casseliflavus*      CGG GGA AGA TGG CAG TAT\             488                  [@B52]
                          CGC AGG GAC GGT GAT TTT                                   

  *E. gallinarum*         GGT ATC AAG GAA ACC TC\              822                  [@B52]
                          CTT CCG CCA TCA TAG CT                                    

  *E. durans*             CCT ACT GAT ATT AAG ACA GCG\         295                  [@B45]
                          TAA TCC TAA GAT AGG TGT TTG                               

  *E. hirae*              CTT TCT GAT ATG GAT GCT GTC\         187                  [@B45]
                          TAA ATT CTT CCT TAA ATG TTG                               

  *cyl*A                  ACT CGG GGA TTG ATA GGC\             688                  [@B102]
                          GCT GCT AAA GCT GCG CTT                                   

  *Ace*                   AAA GTA GAA TTA GAT CCA CAC\         320                  [@B64]
                          TCTA TCA CAT TCG GTT GCG                                  

  *efa*A                  CGT GAG AAA GAA ATG GAG GA\          499                  [@B64]
                          CTA CTA ACA CGT CCA CGA ATG                               

  *gel*E                  AGT TCA TGT CTA TTT TCAC\            402                  [@B64]
                          CTT CAT TAT TTA CAC GT TTG                                

  *Agg*                   CCA GTA ATC AGT CCA GAA ACA AACC\    406                  [@B64]
                          TAG CTT TTT TCA TTC TTG TGT TTG TT                        

  *Esp*                   TTA CCA AGA TGG TTC TGT AGG CAC\     913                  [@B88]
                          CCA AGT ATA CTT AGC ATC TTT TGG                           

  *Cpd*                   TGG TGG GTT ATT TTT CAA TTC\         782                  [@B29]
                          TAC GGC TCT GGC TTA CTA                                   

  *Ccf*                   GGG AAT TGA GTA GTG AAG AAG\         543                  [@B29]
                          AGC CGC TAA AAT CGG TAA AAT                               

  *Cob*                   AAC ATT CAG CAA ACA AAGC\            1405                 [@B29]
                          TTG TCA TAA AGA GTG GTCAT                                 

  *cyl*L                  GATGGAGGGTAAGAATTATGG\               253                  [@B87]
                          GCTTCACCTCACTAAGTTTTATAG                                  

  *Hyl*                   ACAGAAGAGCTGCAGGAAATG\               276                  [@B102]
                          GACTGACGTCCAAGTTTCCAA                                     

  *sprE*                  TTGAGCTCCGTTCCTGCCGAAAGTCATTC\       591                  [@B72]
                          TTGGTACCGATTGGGGAACCAGATTGACC                             

  *mph*C                  GAGA CTAC CAAG AAGA CCTGACG\         722                  [@B62]
                          CATA CGCC GATT CTCC TGAT                                  

  *van*B                  AGACATTCCGGTCGAGGAAC\                220                  [@B74]
                          GCTGTCAATTAGTGCGGGAA                                      

  *van*A                  GCGCGGTCCACTTGTAGATA\                314                  [@B74]
                          TGAGCAACCCCCAAACAGTA                                      

  *van*C-2/3              CTAGCGCAATCGAAGCACTC\                582                  [@B74]
                          GTAGGAGCACTGCGGAACAA                                      

  *van*C-1                ATCCAAGCTATTGACCCGCT\                402                  [@B74]
                          TGTGGCAGGATCGTTTTCAT                                      

  *erm*A                  GCGGTAAACCCCTCTGAG\                  434                  [@B103]
                          GCCTGTCGGAATTGG                                           

  *erm*B                  CATT TAAC GACG AAAC TGGC\            425                  [@B49]
                          GGAA CATC TGTG GTAT GGCG                                  

  *erm*C                  ATCT TTGA AATC GGCT CAGG\            295                  [@B49]
                          CAAA CCCG TATT CCAC GATT                                  

  *tet*M                  GTGGACAAAGGTACAACGAG\                406                  [@B75]
                          CGGTAAAGTTCGTCACACAC                                      

  *tet*A                  GCT ACA TCC TGC TTG CCTTC\           210                  [@B75]
                          CAT AGA TCG CCG TGA AGAGG                                 

  *tet*B                  TTG GTTA GGG GCA AGT TTTG\           659                  [@B75]
                          GTA ATG GGC CAA TAA CACCG                                 

  *tet*C                  CTTGAGAGCCTTCAACCCAG\                418                  [@B75]
                          ATGGTCGTCATCTACCTGCC                                      

  *tet*D                  AAA CCA TTAC GGCA TTC TGC\           787                  [@B75]
                          GAC CGG ATA CAC CAT CCATC                                 
  ----------------------------------------------------------------------------------------------

Antibiotic Susceptibility Profile of *Enterococcus* Isolates
------------------------------------------------------------

The antimicrobial susceptibility profile of the *Enterococcus* species was determined using the Kirby--Bauer disc diffusion method. Briefly, the purified isolates were inoculated in 5.0 mL of Mueller--Hinton Broth (MHB; Lab M, Lancashire, United Kingdom) and incubated overnight. The optical density (OD) of the turbidity of the broth was determined to conform to the OD 0.5 of the McFarland standard where the cells are equivalent to 10^6^ cfu/mL. Using sterile swab sticks, the respective broth cultures were aseptically swabbed on Mueller--Hinton Agar (Lab M, Lancashire, United Kingdom). A total of 14 antibiotic discs (Mast Diagnostics, United Kingdom) that include penicillin G (10 units), piperacillin(100 μg), clindamycin (2 μg), vancomycin (30 μg), teicoplanin (30 μg), erythromycin (15 μg), tetracycline (30 μg), tigecycline (15 μg), kanamycin (30 μg), imipenem (10 μg), norfloxacin (10 μg), ciprofloxacin (5 μg), chloramphenicol (30 μg), and rifampin (5 μg) were used for susceptibility testing. The respective discs were also aseptically impregnated on the agar plates using sterile forceps spaced equidistant apart. Plates were allowed to stand at 28 ± 2°C for 5 min to allow the media to absorb effectively and incubated at 37°C for 18--24 h. Characterization of the resistance, susceptibility, or intermediate profile of the isolates was elucidated by measuring the zone of inhibition and compared with a standard interpretative chart to determine the sensitive, intermediate, and resistance pattern of the isolates to the antibiotics used using the [@B24] interpretative chart.

The multiple antibiotic resistance index (MARI) was calculated as previously described by [@B55]. Multidrug resistance profile was described as resistance to a minimum of one antibiotic in a minimum of three antimicrobial classes ([@B63]).

Multiple antibiotic resistance index

=

Number of

antibiotics to which resistance occured

Total number of antibiotics to which the isolates were tested

Phenotypic Virulence and Biofilm Formation
------------------------------------------

The phenotypic virulence profile of the isolates was determined as previously modified by [@B7]. Colonies cultivated on tryptone soy agar (TSA; Merck, Darmstadt, Germany) were resuspended in 20 mL of TSB. The turbidity of this suspension was adjusted to 10^6^ cells/mL. Hemolytic activity was determined on a sheep blood agar plate. Lipase activity was elucidated on TSA. Gelatinase production was determined on gelatin medium. DNA-degrading activity was ascertained on DNase agar plates. The presence of surface-layer (S-layer) was assessed by streaking cultures on TSA plates, enhanced with 0.1 mg/mL Coomassie brilliant blue R 250 (Merck, Darmstadt Germany). All experiments were performed in triplicate.

Biofilm formation was assessed using the modified protocol of [@B44]. Briefly, purified colonies of *Enterococcus* species were resuspended in 10 mL of tryptone soy broth, incubated at 37°C for 18 h, and centrifuged for 2 min at 12,000 rpm. The cell pellets were washed in phosphate-buffered solution (PBS) with their adherence properties determined via the wells of sterile 96-well polystyrene microtiter plates with sterile TSB broth as negative control. *E. faecalis* (ATCC 19433) was used as a positive control. The microtiter plates were incubated for 24 h at 37°C, washed with sterile PBS, allowed to dry at 28 ± 2°C, and stained with crystal violet for 30 min. The wells were washed again with sterilized deionized water and left to dry at room temperature. Crystal violet dye bound to adherent cells was resuspended in 150 mL of 99% ethanol. The OD readings from respective wells were determined at 570 nm via a microtiter plate reader (Synergy Mx Biotek^®^, United States). Each assay was determined three times to obtain the mean value. Biofilm formation was characterized as a negative, weak, moderate, or strong producer in accordance with methods previously described by [@B4].

Antibiotic Resistance and Virulence Gene Determination
------------------------------------------------------

Macrolide-resistant genes (*mph*C, *erm*C, *erm*B, and *erm*A) were detected via PCR following the procedure of [@B85] using primers presented in [Table 1](#T1){ref-type="table"}. PCR program conditions include an initial denaturation step for 5 min at 94°C followed by 30 cycles, which includes denaturation for 60 s at 94°C, with the following respective annealing temperature regimen: *erm*A (51°C), *erm*B (51°C), *erm*C (51°C), and *mph*C (55°C) for 60 s, and extension for 60 s at 72°C with a final extension for 5 min at 72°C in one cycle, which ended the procedure. PCR conditions for *van*A, *van*B, *van*C-1, and *van*C-2/3 include a denaturation step of 94°C for 3 min, 35 cycles of denaturation at 94°C for 1 min, annealing at 56.5°C for 1 min, extension at 72°C for 1 min, followed by an elongation step at 72°C for 10 min. PCR conditions for *tet*A, *tet*B, *tet*C, *tet*D, and *tet*M genes include an initial denaturation for 5 min at 94°C, followed by 10 cycles of denaturation for 30 s at 94°C; annealing for 30 s at 58°C for *tet*A, *tet*B, *tet*C, and *tet*D; annealing for 30 s at 57°C for *tet*M; and extension for 45 s at 72°C. The Peltier-Based Thermal Cycler (MG96Þ/Y, Hangzhou, Zhejiang China) was used in the amplification process. Electrophoresis of the PCR amplicons was performed with 1.5% agarose gel (CLS-AG100, Warwickshire, United Kingdom) in 0.5× TAE buffer (40 mM Tris-HCl, pH 8.5, 1 mM EDTA, and 20 mM Na acetate) and allowed to run for 1 h at 100 V. The gels are visualized under a UV transilluminator (EBOX VX5, Vilber Lourmat, France).

Virulence genes such as enterococcal surface protein (*esp*), serine protease (*spr*E), gelatinase (*gel*E), enterococcal surface adhesion (*ace*), enterococcal cytolysin (*cyl*L), cytolysin operon (*cyl*A), aggregation substance (*agg*), sex pheromones (*ccf, cob*, and *cpd*), hyaluronidase (*hyl*), and cell wall adhesins (*efa*A) were amplified via PCR using specific primers in [Table 1](#T1){ref-type="table"} and conditions previously described ([@B88]; [@B29]; [@B72]; [@B64]; [@B87]; [@B102]). The Peltier-Based Thermal Cycler (MG96Þ/Y, Hangzhou, Zhejiang, China) was used in the amplification process. Electrophoresis of the PCR amplicons was performed with 1.5% agarose gel (CLS-AG100, Warwickshire, United Kingdom) in 0.5× TAE buffer (40 mM Tris-HCl, pH 8.5, 1 mM EDTA, and 20 mM Na acetate) and allowed to run for 1 h at 100 V. The gels are visualized under a UV transilluminator (EBOX VX5, Vilber Lourmat, France).

Results
=======

Prevalence of *Enterococcus* Species From the Shrimps
-----------------------------------------------------

Prevalence of *Enterococcus* species from shrimp varieties as shown in [Table 2](#T2){ref-type="table"} is as follows: sauced, 26 (9.03%); boiled, 6 (2.78%); and smoked, 27 (12.50%). From the different markets sampled, the prevalence is as follows: ESM (*Enterococcus* from Sapele market), 7 (5.83%); EUMM (*Enterococcus* from Ughelli main market), 9 (7.50%); EOMA (*Enterococcus* from Ogbegonogo market, Asaba), 8 (6.67%); EAMA (*Enterococcus* from Ashafor market, Aniocha), 10 (8.33%); EIMN (*Enterococcus* from Igbudu market, Warri), 14 (11.67%); and MOI (*Enterococcus* from main market, Oleh, Isoko), 11 (9.17%). An overall prevalence of 59 (8.19%) was recorded from the shrimps.

###### 

Prevalence of *Enterococcus* species from ready-to-eat shrimp variety.

                            No. of samples examined   No. of positive samples (%)
  ---------------- -------- ------------------------- -----------------------------
  Shrimp variety   Sauced   288                       26 (9.03)
                   Boiled   216                       6 (2.78)
                   Smoked   216                       27 (12.50)
                   Total    720                       59 (8.19)
  Market sampled   ESM      120                       7 (5.83)
                   EUMM     120                       9 (7.50)
                   EOMA     120                       8 (6.67)
                   EAMA     120                       10 (8.33)
                   EIMN     120                       14 (11.67)
                   MOI      120                       11 (9.17)
                   Total    720                       59 (8.19)
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Distribution Profile of Enterococci From the Shrimps
----------------------------------------------------

The distribution of *Enterococcus* species is as follows: *E. faecalis*, 17 (28.8%); *E. faecium*, 29 (49.2%); *E. gallinarum*, 6 (10.2%); *E. casseliflavus*, 2 (3.4%); *E. hirae*, 3 (5.1%); and *E. durans*, 2 (3.4%). Four different *Enterococcus* species (*E. faecium, E. faecalis, E. hirae*, and *E. gallinarum*) were recovered from sauced shrimps; two different *Enterococcus* species (*E. faecium* and *E. faecalis*) were recovered from boiled shrimps, while five different *Enterococcus* species (*E. casseliflavus, E. faecalis, E. durans, E. faecium*, and *E. hirae*) were recovered from smoked shrimps ([Table 3](#T3){ref-type="table"}).

###### 

Phenotypic and genotypic virulence characterization of *Enterococcus* species from RTE shrimps varieties.

  Isolate code   *Enterococcus* sp.   Phenotypic virulence   Genotypic virulence                                           Shrimp variety   Biofilm formation
  -------------- -------------------- ---------------------- ------------------------------------------------------------- ---------------- -------------------
  ESM-1          *E. faecium*         S-layer, gel           *gel*E-*spr*E-*agg-efa*A-*cpd*-*cob-ccf-esp-hyl*              Sauced           Moderate
  ESM-2          *E. faecalis*        S-layer                *agg-efa*A*-ace*-*cpd-cob-ccf-ccf-esp-hyl*                    Boiled           Strong
  ESM-3          *E. casseliflavus*   S-layer                *agg-ace*-*cpd-cob-ccf-esp*                                   Smoked           Negative
  ESM-4          *E. faecium*         S-layer, β-hem, gel    *gel*E-*spr*E-*agg-efa*A*-ace*-*cpd-cob-ccf-esp-hyl*          Sauced           Moderate
  ESM-5          *E. faecalis*        S-layer                *efa*A*-cpd-ace-cob-esp-hyl*                                  Smoked           Moderate
  ESM-6          *E. casseliflavus*   S-layer                *cob-ace-ccf-esp*                                             Smoked           Moderate
  ESM-7          *E. faecalis*        S-layer, gel           *spr*E-*agg-efa*A*-ace*-*cob-ccf-esp-hyl*                     Sauced           Strong
  EUMM-1         *E. faecalis*        S-layer, β-hem         *cyl*L-*agg-efa*A-*cpd-cob-ccf-hyl*                           Smoked           Negative
  EUMM-2         *E. faecium*         S-layer                *efa*A*-cob-ace-ccf-esp-hyl*                                  Sauced           Moderate
  EUMM-3         *E. faecium*         S-layer, β-hem, gel-   *gel*E*-ace*-*spr*E-*cyl*L-*agg-efa*A-*cpd-cob-ccf-esp-hyl*   Smoked           Negative
  EUMM-4         *E. hirae*           S-layer                *cpd-efa*A*-cob-ace-esp*                                      Sauced           Negative
  EUMM-5         *E. faecalis*        S-layer, gel           *gel*E*-efa*A-*spr*E-*cob-ace-ccf-esp-hyl*                    Boiled           Weak
  EUMM-6         *E. faecium*         S-layer                *agg-efa*A*-ace-cpd-cob-ccf-esp-hyl*                          Smoked           Moderate
  EUMM-7         *E. faecium*         S-layer, β-hem         *cpd-efa*A*-cob-ace-ccf-esp-hyl*                              Sauced           Weak
  EUMM-8         *E. faecium*         S-layer, β-hem, gel-   *gel*E*-efa*A*-spr*E-*agg-ace-cob ccf-esp-hyl*                Smoked           Negative
  EUMM-9         *E. faecium*         S-layer, β-hem         *cpd-efa*A*-ace-cob-ccf-esp-hyl*                              Smoked           Moderate
  EOMA-1         *E. faecalis*        S-layer, gel           *gel*E*-ace-spr*E-*agg-efa*A*-cpd-cob-ccf-esp*                Sauced           Moderate
  EOMA-2         *E. faecalis*        S-layer                *cpd-efa*A*-ace-cob-ccf-esp*                                  Boiled           Strong
  EOMA-3         *E. faecium*         S-layer                *cob-efa*A*-ccf-ace-esp-hyl*                                  Smoked           Weak
  EOMA-4         *E. faecium*         S-layer, gel           *gel*E*-efa*A*-spr*E-*cpd-ace-cob-ccf-esp-hyl*                Sauced           Moderate
  EOMA-5         *E. faecium*         S-layer, gel           *gel*E*-efa*A*-spr*E-*cpd-ace-cob-ccf-esp-hyl*                Smoked           Moderate
  EOMA-6         *E. durans*          S-layer                *agg-esp-cpd-cob-ccf*                                         Smoked           Negative
  EOMA-7         *E. faecium*         S-layer, gel           *gel*E*-ace-spr*E*-agg-efa*A*-cpd-cob-ccf-esp-hyl*            Boiled           Negative
  EOMA-8         *E. gallinarum*      S-layer                *cpd-esp-cob-ccf*                                             Smoked           Moderate
  EAMA-1         *E. gallinarum*      S-layer                *agg-esp-cpd-cob-ccf*                                         Smoked           Negative
  EAMA-2         *E. faecium*         S-layer, β-hem, gel    *gel*E*- efa*A*-ace-spr*E-*cyl*L-*agg*-*cob-ccf-esp-hyl*      Smoked           Negative
  EAMA-3         *E. faecalis*        S-layer, β-hem, gel    *gel*E*-efa*A*-spr*E-*agg-ace-cpd-cob-ccf-esp-hyl*            Sauced           Weak
  EAMA-4         *E. faecium*         S-layer                *cob-efa*A*-ccf-ace-esp-hyl*                                  Smoked           Moderate
  EAMA-5         *E. faecium*         S-layer                *agg-efa*A*-cpd-ace-cob-ccf-esp-hyl*                          Smoked           Strong
  EAMA-6         *E. faecalis*        S-layer                *cob-efa*A*-ccf-esp-ace-hyl*                                  Sauced           Weak
  EAMA-7         *E. faecium*         S-layer, β-hem         *cpd-efa*A*-ace-cob-ccf-esp-hyl*                              Smoked           Negative
  EAMA-8         *E. faecium*         S-layer, β-hem, gel    *gel*E*-ace-spr*E-*agg-efa*A*-cpd-cob-ccf-esp-hyl*            Sauced           Moderate
  EAMA-9         *E. gallinarum*      S-layer                *cob-esp-ccf*                                                 Smoked           Moderate
  EAMA-10        *E. faecium*         S-layer, β-hem         *agg-efa*A*-cpd-ace-cob-ccf-esp-hyl*                          Sauced           Moderate
  EIMW-1         *E. faecium*         S-layer                *agg-efa*A*-cob-ace-esp-hyl*                                  Sauced           Strong
  EIMW-2         *E. faecium*         S-layer, gel           *gel*E-*spr*E*-efa*A*-agg*-*cpd-cob-ace-ccf-esp-hyl*          Sauced           Negative
  EIMW-3         *E. faecalis*        S-layer                *agg-efa*A*-cob-ace-ccf-esp-hyl*                              Sauced           Weak
  EIMW-4         *E. faecalis*        S-layer, β-hem         *cyl*L-*agg-efa*A*-ace-cob-ccf-esp-hyl*                       Smoked           Weak
  EIMW-5         *E. faecium*         S-layer                *cob-efa*A*-ccf-ace-esp-hyl*                                  Smoked           Moderate
  EIMW-6         *E. faecium*         S-layer, β-hem, gel    *gel*E*-ace-spr*E-*agg-efa*A*-cpd-cob-ccf-esp-hyl*            Smoked           Moderate
  EIMW-7         *E. faecium*         S-layer, β-hem         *cob-efa*A*-ace-ccf-esp-hyl*                                  Sauced           Weak
  EIMW-8         *E. faecalis*        S-layer                *agg-efa*A*-cob-ace-ccf-esp-hyl*                              Boiled           Weak
  EIMW-9         *E. faecium*         S-layer                *agg-efa*A*-cob-ace-ccf-esp-hyl*                              Smoked           Moderate
  EIMW-10        *E. faecium*         S-layer, β-hem, gel    *gel*E*-efa*A*-spr*E-*agg-ace-cpd-cob-ccf-esp-hyl*            Sauced           Negative
  EIMW-11        *E. faecalis*        S-layer, β-hem         *cyl*L*-ace-agg*-*cpd-efa*A*-cob-ccf-esp-hyl*                 Smoked           Negative
  EIMW-12        *E. gallinarum*      S-layer                *cob-esp-ccf*                                                 Sauced           Negative
  EIMW-13        *E. gallinarum*      S-layer                *agg-esp-cpd-cob-ccf*                                         Sauced           Moderate
  EIMW-14        *E. faecium*         S-layer, gel           *gel*E*-efa*A*-ace-spr*E-*agg*-*ccf-esp-hyl*                  Sauced           Strong
  MOI-1          *E. faecalis*        S-layer, β-hem         *agg-efa*A*-ace-cpd-cob-ccf-esp-hyl*                          Smoked           Negative
  MOI-2          *E. faecalis*        S-layer, β-hem         *agg-efa*A*-esp-cpd-cob-ccf-hyl*                              Smoked           Weak
  MOI-3          *E. faecium*         S-layer, β-hem, gel    *gel*E*-ace-spr*E-*agg-efa*A*-cpd-cob-ccf-esp-hyl*            Sauced           Negative
  MOI-4          *E. durans*          S-layer                *agg-esp-cpd-cob-ccf*                                         Smoked           Moderate
  MOI-5          *E. faecium*         S-layer, β-hem         *cyl*L*-ace-agg-efa*A*-cob-ccf-esp-hyl*                       Sauced           Negative
  MOI-6          *E. faecium*         S-layer                *cob-ace-efa*A*-ccf-esp-hyl*                                  Sauced           Moderate
  MOI-7          *E. faecalis*        S-layer, β-hem, gel    *gel*E*-ace-spr*E-*agg-efa*A*-cob-ccf-esp-hyl*                Boiled           Moderate
  MOI-8          *E. faecalis*        S-layer                *cpd-ace-cob-ccf-esp-hyl*                                     Sauced           Strong
  MOI-9          *E. hirae*           S-layer                *cpd-esp-cob-ccf*                                             Sauced           Negative
  MOI-10         *E. hirae*           S-layer                *agg-esp-cob-ccf*                                             Smoked           Negative
  MOI-11         *E. gallinarum*      S-layer                *agg-ace-cpd-esp-cob*                                         Sauced           Weak

ESM,

Enterococcus

from Sapele market; EUMM,

Enterococcus

from Ughelli main market; EOMA,

Enterococcus

from Ogbegonogo market, Asaba; EAMA,

Enterococcus

from Ashafor market, Aniocha; EIMW,

Enterococcus

from Igbudu market, Warri; MOI,

Enterococcus

from main market, Oleh, Isoko; β-hem, beta-hemolysis; gel, gelatinase activity.

Biofilm formation of the *Enterococcus* species includes the following: non-formers, 19 (32%); weak formers, 11 (19%); moderate formers, 22 (37%); and strong formers, 7 (12%). Overall, 40 (67.8%) were biofilm formers. Biofilm occurrence among the shrimp varieties is as follows: 19/26 (73.1%) for sauced shrimps, 5/6 (83.3%) for boiled shrimps, and 16/27 (59.3%) for smoked shrimps ([Table 3](#T3){ref-type="table"}).

Phenotypic and Genotypic Expression of Virulence Determinants in the Enterococci
--------------------------------------------------------------------------------

The phenotypic expression of the enterococci isolates for virulence in this study as presented in [Table 3](#T3){ref-type="table"} revealed the following: 59 (100%) for S-layer, 19 (32.2%) for gelatinase production, and 21 (35.6%) for β-hemolysis. The genotypic expression of virulence as presented in [Table 3](#T3){ref-type="table"} is as follows: *gel*E, 18 (30.5%); *spr*E, 19 (32.2%); *cyl*L, 6 (10.2%); *agg*, 37 (62.7%); *cpd*, 36 (61.0%); *cob*, 58 (98.3%); *ccf*, 56 (94.9%); *efa*A, 46 (77.9%); *esp*, 58 (98.3%); *ace*, 47 (79.7%); and *hyl*, 44 (74.6%). An average of 3--11 virulence genes was detected in the *Enterococcus* species. None of the enterococci isolates was simultaneously positive to all tested virulence genes. Screened sex pheromone genes (*cpd, cob*, and *ccf*) were detected in 32 (54.2%) of the enterococci isolates. Furthermore, 52 (88.1%) enterococci isolates had both the *cob* and *ccf* genes. The *cyl*A gene was not detected in any of the enterococci. The *cyl*L gene was present in *E. faecalis* and *E. faecium*, which were isolated from five smoked and one sauced shrimp variety ([Table 3](#T3){ref-type="table"}).

No isolate produced lipase or was positive for DNA-degrading activity. All *gel*E gene-carrying enterococci phenotypically expressed the gelatinase activity. However, one of the isolates that phenotypically expressed the gelatinase activity lacked the *gel*E gene. All *cyl*L gene-carrying isolates expressed β-hemolytic activity. However, not all the isolates that phenotypically expressed the β-hemolytic activity harbored the *cyl*L gene ([Table 3](#T3){ref-type="table"}). From the *esp* gene detected, all the isolates phenotypically expressed the S-layer activity. However, one isolate with S-layer expressed phenotypically lacked the *esp* gene but harbored the *efa*A gene ([Table 3](#T3){ref-type="table"}). Although 40 (67.8%) of the isolates were biofilm formers phenotypically, all 40/40 (100%) of the biofilm producers harbored the *esp* gene and displayed S-layer characteristics, and 12/40 (30%) harbored the *gel*E gene. However, some of the isolates with the *esp* gene, *gel*E gene, and S-layer characteristics did not produce biofilm ([Table 3](#T3){ref-type="table"}).

Antibiotic Susceptibility Profile of the *Enterococcus* Species
---------------------------------------------------------------

The resistance profile of *Enterococcus* species in [Table 4](#T4){ref-type="table"} is as follows: penicillin G, 52 (88.1%); piperacillin, 23 (38.9%); clindamycin, 40 (67.8%); erythromycin, 29 (49.2%); vancomycin, 22 (37.3%); teicoplanin, 32 (54.2%); and tetracycline, 27 (45.8%).

###### 

Antibiotic susceptibility profile of the *Enterococcus* species from shrimps.

  Antimicrobial class   Antibiotics   *E. faecalis* (*n* = 17)   *E. faecium* (*n* = 29)   *E. gallinarum* (*n* = 6)   *E. casseliflavus* (*n* = 2)   *E. hirae* (*n* = 3)   *E. durans* (*n* = 2)   Total (*n* = 59)                                                                                        
  --------------------- ------------- -------------------------- ------------------------- --------------------------- ------------------------------ ---------------------- ----------------------- ------------------ ------ ------ ----- ----- ----- ------ ------ ------ ----- ----- ----- ------ ------ ------
  Penicillins           PEN           100                        0                         0                           82.8                           0                      17.2                    66.7               0      33.3   100   0     0     100    0      0      100   0     0     88.1   0      11.9
                        PTZ           41.2                       29.4                      29.4                        37.9                           34.5                   27.6                    33.3               50     16.7   0     50    50    66.7   0      33.3   50    0     50    38.9   32.2   28.8
  Lincosamides          CLI           70.6                       29.4                      0                           72.4                           10.4                   17.2                    33.3               16.7   50     50    0     50    66.7   33.3   0      100   0     0     67.8   16.9   15.3
  Macrolides            ERY           52.9                       47                        0                           62.1                           27.6                   10.4                    33.3               66.7   0      0     100   0     0      100    0      0     100   0     49.2   45.8   5.1
  Glycopeptides         VAN           47.1                       17.7                      35.3                        44.8                           31.1                   24.1                    16.7               50     33.3   0     0     100   0      0      100    0     50    50    37.3   27.1   36.6
                        TEC           58.8                       29.4                      11.8                        62.1                           10.4                   27.6                    33.3               0      66.7   50    50    0     33.3   0      66.7   0     0     100   54.2   12.3   30.5
  Tetracyclines         TET           52.9                       17.7                      29.4                        51.7                           27.6                   20.7                    33.3               16.7   50     0     50    50    33.3   66.7   0      0     50    50    45.8   27.1   27.1
                        TGC           64.7                       11.8                      23.5                        62.1                           13.8                   24.1                    33.3               16.7   50     0     0     100   33.3   0      66.7   0     0     100   54.2   11.9   33.9
  Aminoglycosides       KAN           17.7                       5.8                       76.4                        10.4                           20.7                   68.9                    0                  0      100    0     0     100   0      0      100    0     0     100   10.2   11.9   77.9
  Carbapenems           IMI           17.7                       0                         82.3                        10.4                           31.1                   58.6                    0                  0      100    0     0     100   0      33.3   66.7   0     0     100   10.2   18.9   72.9
  Quinolones            NOR           41.1                       17.6                      41.1                        10.4                           6.9                    82.8                    0                  0      100    0     0     100   0      0      100    0     0     100   16.9   8.5    74.6
                        CIP           47.1                       11.8                      41.1                        41.4                           3.5                    55.2                    16.7               0      83.3   0     0     100   0      0      100    0     0     100   35.6   5.1    59.3
  Phenicols             CHL           23.5                       58.8                      17.7                        24.1                           41.4                   34.5                    33.3               66.7   0      0     100   0     0      100    0      0     100   0     22.0   55.9   22.0
  Ansamycins            RIF           29.4                       0                         70.5                        17.2                           3.5                    79.3                    16.7               16.7   66.7   0     0     100   0      0      100    0     0     100   18.6   3.4    77.9

PEN, penicillin G; PTZ, piperacillin; CLI, clindamycin; ERY, erythromycin; VAN, vancomycin; TEC, teicoplanin; TET, tetracycline; TGC, tigecycline; KAN, kanamycin; IMI, imipenem; NOR, norfloxacin; CIP, ciprofloxacin; CHL, chloramphenicol; RIF, rifampin.

Multiple Antibiotic Resistance Profile and Antibiotic Resistance Determinants
-----------------------------------------------------------------------------

The multiple drug resistance (MDR) profile of the *Enterococcus* species revealed resistance to a minimum of three antibiotics that belong to three antimicrobial classes with a MARI of 0.21 and a maximum of 14 antibiotics that belong to 10 antimicrobial classes with a MARI of 1. A total of 37 (62.7%) isolates were multidrug resistant ([Table 5](#T5){ref-type="table"}). The occurrence of antibiotic resistance elements detected in [Table 5](#T5){ref-type="table"} from the phenotypically resistant enterococci isolates to the macrolide, glycopeptide, and tetracycline antibiotics is as follows: *erm*A, 13/29 (44.8%); *mph*C, 13/29 (44.8%); *van*A, 14/22 (63.6%); *tet*A, 14/27 (51.9%); *tet*M, 15/27 (55.6%); *erm*B, 4/29 (13.8%); and *van*B, 5/22 (22.7%). None of *van*C-1, *van*C-2/3, *tet*B, *tet*C, and *tet*D was detected.

###### 

Multidrug resistance profile, resistance phenotype, and resistance determinants of *Enterococcus* species from shrimps.

  Isolate code   *Enterococcus* sp.   Shrimp variety   Biofilm formation   No. of antimicrobial class   No. of antibiotics   Resistance phenotype                                                                                MAR index   Resistance gene
  -------------- -------------------- ---------------- ------------------- ---------------------------- -------------------- --------------------------------------------------------------------------------------------------- ----------- -------------------------------------------
  ESM-1          *E. faecium*         Sauced           Moderate            6                            7                    PEN^R^-CLI^R^-ERY^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^                                                    0.50        *erm*A-*mph*C-*van*A-*tet*A-*tet*M
  ESM-2          *E. faecalis*        Boiled           Strong              3                            4                    PEN^R^-CLI^R^-TGC^R^-TEC^R^                                                                         0.29        
  ESM-3          *E. casseliflavus*   Smoked           Negative            1                            1                    PEN^R^                                                                                              0.07        
  ESM-4          *E. faecium*         Sauced           Moderate            7                            8                    PEN^R^-KAN^R^-TET^R^-CLI^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^                                             0.57        *tet*A
  ESM-5          *E. faecalis*        Smoked           Moderate            1                            1                    PEN^R^                                                                                              0.07        
  ESM-6          *E. casseliflavus*   Smoked           Moderate            3                            3                    PEN^R^-CLI^R^-TEC^R^                                                                                0.21        
  ESM-7          *E. faecalis*        Sauced           Strong              8                            12                   PEN^R^-PTZ^R^-IMI^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-NOR^R^                 0.86        *erm*A-*erm*B-*mph*C-*tet*A
  EUMM-1         *E. faecalis*        Smoked           Negative            1                            1                    PEN^R^                                                                                              0.07        
  EUMM-2         *E. faecium*         Sauced           Moderate            8                            11                   PEN^R^-KAN^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-NOR^R^-CHL^R^                        0.79        *erm*A-*erm*B-*mph*C-*van*A-*tet*A-*tet*M
  EUMM-3         *E. faecium*         Smoked           Negative            6                            9                    PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^                                      0.64        *mph*C-*van*A
  EUMM-4         *E. hirae*           Sauced           Negative            1                            1                    PEN^R^                                                                                              0.07        
  EUMM-5         *E. faecalis*        Boiled           Weak                4                            4                    PEN^R^-CLI^R^-TGC^R^-TEC^R^                                                                         0.29        
  EUMM-6         *E. faecium*         Smoked           Moderate            2                            2                    PEN^R^-CLI^R^                                                                                       0.14        
  EUMM-7         *E. faecium*         Sauced           Weak                10                           14                   PEN^R^-PTZ^R^-IMI^R^-KAN^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-NOR^R^-CHL^R^   1           *erm*A-*van*A-*van*B-*tet*A-*tet*M
  EUMM-8         *E. faecium*         Smoked           Negative                                                              --                                                                                                  --          
  EUMM-9         *E. faecium*         Smoked           Moderate            2                            2                    PEN^R^-CLI^R^                                                                                       0.14        
  EOMA-1         *E. faecalis*        Sauced           Moderate            7                            11                   PEN^R^-PTZ^R^-KAN^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-NOR^R^                        0.79        *erm*A-*mph*C-*van*A-*van*B-*tet*A
  EOMA-2         *E. faecalis*        Boiled           Strong              8                            12                   PEN^R^-PTZ^R^-IMI^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-NOR^R^-CHL^R^                 0.86        *erm*A-*mph*C-*tet*M
  EOMA-3         *E. faecium*         Smoked           Weak                1                            1                    PEN^R^                                                                                              0.07        
  EOMA-4         *E. faecium*         Sauced           Moderate                                                              --                                                                                                  --          
  EOMA-5         *E. faecium*         Smoked           Moderate            6                            7                    PEN^R^-CLI^R^-ERY^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^                                                    0.50        *erm*A
  EOMA-6         *E. durans*          Smoked           Negative            2                            2                    PEN^R^-CLI^R^                                                                                       0.14        
  EOMA-7         *E. faecium*         Boiled           Negative            7                            10                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^                               0.71        *erm*A-*tet*A
  EOMA-8         *E. gallinarum*      Smoked           Moderate            6                            8                    PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-TGC^R^-TEC^R^-CHL^R^                                             0.57        *tet*M
  EAMA-1         *E. gallinarum*      Smoked           Negative            1                            1                    PEN^R^                                                                                              0.07        
  EAMA-2         *E. faecium*         Smoked           Negative            5                            5                    PEN^R^-CLI^R^-ERY^R^-TGC^R^-TEC^R^                                                                  0.36        
  EAMA-3         *E. faecalis*        Sauced           Weak                7                            10                   PEN^R^-PTZ^R^-IMI^R^-KAN^R^-TET^R^-CIP^R^-VAN^R^-TGC^R^-NOR^R^-CHL^R^                               0.71        *van*A-*tet*A
  EAMA-4         *E. faecium*         Smoked           Moderate            5                            6                    PEN^R^-TET^R^-CLI^R^-ERY^R^-TGC^R^-TEC^R^                                                           0.43        *mph*C-*tet*M
  EAMA-5         *E. faecium*         Smoked           Strong              1                            1                    PEN^R^                                                                                              0.07        
  EAMA-6         *E. faecalis*        Sauced           Weak                6                            6                    PEN^R^-CLI^R^-ERY^R^-TGC^R^-TEC^R^-RIF^R^                                                           0.43        *erm*A-*erm*B
  EAMA-7         *E. faecium*         Smoked           Negative            1                            1                    PEN^R^                                                                                              0.07        
  EAMA-8         *E. faecium*         Sauced           Moderate            5                            7                    PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-TGC^R^-TEC^R^                                                    0.50        *mph*C-*tet*A
  EAMA-9         *E. gallinarum*      Smoked           Moderate                                                              --                                                                                                  --          
  EAMA-10        *E. faecium*         Sauced           Moderate            8                            11                   PEN^R^-PTZ^R^-IMI^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-CHL^R^                        0.79        *mph*C-*van*A
  EIMW-1         *E. faecium*         Sauced           Strong              7                            9                    PEN^R^-PTZ^R^-IMI^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-TGC^R^-TEC^R^                                      0.64        *tet*M
  EIMW-2         *E. faecium*         Sauced           Negative            3                            3                    TET^R^-CLI^R^-ERY^R^                                                                                0.21        
  EIMW-3         *E. faecalis*        Sauced           Weak                1                            1                    PEN^R^                                                                                              0.07        
  EIMW-4         *E. faecalis*        Smoked           Weak                9                            12                   PEN^R^-KAN^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-NOR^R^-CHL^R^                 0.86        *erm*A-*van*A-*van*B-*tet*A-*tet*M
  EIMW-5         *E. faecium*         Smoked           Moderate            1                            1                    PEN^R^                                                                                              0.07        
  EIMW-6         *E. faecium*         Smoked           Moderate            4                            5                    PEN^R^-TET^R^-CLI^R^-TGC^R^-TEC^R^                                                                  0.36        *tet*M
  EIMW-7         *E. faecium*         Sauced           Weak                2                            2                    PEN^R^-ERY^R^                                                                                       0.14        
  EIMW-8         *E. faecalis*        Boiled           Weak                3                            3                    PEN^E^-CLI^R^-ERY^R^                                                                                0.21        
  EIMW-9         *E. faecium*         Smoked           Moderate            7                            11                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-NOR^R^-CHL^R^                        0.79        *van*A-*tet*M
  EIMW-10        *E. faecium*         Sauced           Negative            6                            9                    PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^                                      0.64        *erm*A-*tet*M
  EIMW-11        *E. faecalis*        Smoked           Negative            8                            11                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-CHL^R^                        0.79        *van*A-*van*B-*tet*A
  EIMW-12        *E. gallinarum*      Sauced           Negative            1                            1                    PEN^R^                                                                                              0.07        
  EIMW-13        *E. gallinarum*      Sauced           Moderate                                                              --                                                                                                  --          
  EIMW-14        *E. faecium*         Sauced           Strong                                                                --                                                                                                  --          
  MOI-1          *E. faecalis*        Smoked           Negative            1                            1                    PEN^R^                                                                                              0.07        
  MOI-2          *E. faecalis*        Smoked           Weak                6                            10                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-NOR^R^                               0.71        *erm*A-*erm*B-*mph*C-*van*A-*tet*M
  MOI-3          *E. faecium*         Sauced           Negative            8                            11                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-CHL^R^                        0.79        *van*A-*van*B-*tet*A-*tet*M
  MOI-4          *E. durans*          Smoked           Moderate            3                            3                    PEN^R^-PTZ^R^-CLI^R^                                                                                0.21        
  MOI-5          *E. faecium*         Sauced           Negative            7                            9                    PEN^R^-PTZ^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-CHL^R^                                      0.64        *mph*C
  MOI-6          *E. faecium*         Sauced           Moderate            7                            10                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-CHL^R^                               0.71        *erm*A-*van*A-*tet*A-*tet*M
  MOI-7          *E. faecalis*        Boiled           Moderate            3                            3                    PEN^R^-TET^R^-CLI^R^                                                                                0.21        
  MOI-8          *E. faecalis*        Sauced           Strong              8                            11                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-NOR^R^                        0.79        *mph*C
  MOI-9          *E. hirae*           Sauced           Negative            4                            6                    PEN^R^-PTZ^R^-TET^R^-CLI^R^-TGC^R^-TEC^R^                                                           0.43        
  MOI-10         *E. hirae*           Smoked           Negative            2                            3                    PEN^R^-PTZ^R^-CLI^R^                                                                                0.21        
  MOI-11         *E. gallinarum*      Sauced           Weak                8                            11                   PEN^R^-PTZ^R^-TET^R^-CLI^R^-ERY^R^-CIP^R^-VAN^R^-TGC^R^-TEC^R^-RIF^R^-CHL^R^                        0.79        *mph*C-*van*A-*tet*A-*tet*M

ESM,

Enterococcus

from Sapele market; EUMM,

Enterococcus

from Ughelli main market; EOMA,

Enterococcus

from Ogbegonogo market, Asaba; EAMA,

Enterococcus

from Ashafor market, Aniocha; EIMW,

Enterococcus

from Igbudu market, Warri; MOI,

Enterococcus

from main market, Oleh, Isoko; PEN, penicillin G; PTZ, piperacillin; CLI, clindamycin; ERY, erythromycin; VAN, vancomycin; TEC, teicoplanin; TET, tetracycline; TGC, tigecycline; KAN, kanamycin; IMI, imipenem; NOR, norfloxacin; CIP, ciprofloxacin; CHL, chloramphenicol; RIF, rifampin.

A total of 19/26 (73.1%) isolates from sauced shrimps were MDR; all 6/6 (100%) isolates from boiled shrimp were MDR while 12/27 (44.4%) isolates from smoked shrimps were MDR. The relationship between antibiotic resistance and biofilm formation in this study is as follows: moderate biofilm formation (resistant between 0 and 11 antibiotics), weak biofilm formation (resistant between 1 and 14 antibiotics), strong biofilm formation (resistant between 1 and 12 antibiotics), and negative biofilm formation (resistant between 0 and 11 antibiotics; [Table 5](#T5){ref-type="table"}).

Discussion
==========

Enterococci make up the most predominant bacteria group that occur in foods, particularly as a consequence of their resistance to severe conditions in the environment during production technology, coupled with their high adaptability and conditions of food storage. Studies have reported enterococci incidence of seafood origin. Several studies have reported seafood contamination to naturally occur from an environment where fish are usually collected. Cross-contamination can occur as a result of food preparation or processing where bacteria are conveyed from utensils or from contaminated surfaces to seafood that are hygienically safe ([@B89]). When shrimps are harvested, they are usually processed by washing and exported frozen. During washing and freezing, decrease in the levels of bacteria can occur. However, resistant survivors can adulterate the final product traded at an open market, which can be distributed to consumers ([@B104]). An overall prevalence of 59 (8.19%) was recorded from the shrimps in this study. The prevalence of *E. faecalis* from cultured Indian prawn at Damietta governorate, Egypt, was 7% ([@B30]), which was similar to the findings of this study. However, higher prevalence within the range of 16.7--74.1% has been documented previously ([@B53]; [@B48]; [@B47]; [@B81]; [@B11]; [@B15]; [@B70]; [@B71]).

Higher incidence of *E. faecium* was recovered from the *Enterococcus* species in this study. This contradicts the findings from previous studies that reported *E. faecalis* as the most predominant enterococci from food sampled ([@B39]; [@B81]; [@B15]). Similarly, investigations carried out in Tunisia ([@B6]) and Portugal ([@B3]) also revealed contamination of fermented meat products principally with *E. faecium* and *E. faecalis* isolates. [@B70] did not isolate *E. gallinarum* from their study; however, [@B47] isolated *E. gallinarum* from meat and fermented meat products, which coincide with the findings from this study. PCR detection of five species isolated from RTE food samples tested by [@B15] includes *E. faecium, E. hirae, E. faecalis, E. casseliflavus* and *E. durans*, with *E. faecium* (39.7%) and *E. faecalis* (48.7%) accounting for majority of the strains. This was in line with the findings of this study.

Literature has connected virulence in enterococci to diverse factors, such as *esp, gel*E, *ace, ccf, cyl*L, *cpd, agg, cob*, and *efa*A and formation of biofilm ([@B21]). PCR detection of these genes coding virulence showed distinctiveness in virulence between enterococci. *E. faecalis* and *E. faecium* strains harbored extra virulence elements compared to other species, which was in line with findings from previous studies ([@B66]; [@B40]). [@B3] explained that there were no virulence genes detected in *E. faecium* isolates with the detection of the *esp, efa, gel*E, and *agg* genes in *E. faecalis*, which contradicts the findings of this study. [@B46] reported the detection of numerous virulence elements in *E. faecium* (*esp, efa, agg*, and *gel*E) and *E. faecalis* (*esp, efa, gel*E, *ace*, and *agg*) strains recovered from meat and meat products. In addition, [@B46] observed the *ace* gene in one *E. gallinarum* isolate. [@B6] revealed that *E. faecium* strains were positive for *efa* and *gel*E genes. These were in line with the findings of this study.

[@B97] reported that the *gel*E gene is responsible for gelatinase production. Gelatinase is a metalloproteinase that can cleave hemoglobulin, insulin, casein, collagen, gelatin, and fibrinogen, in addition to numerous peptides/proteins ([@B38]). The findings from this study revealed that all enterococci positive for the *gel*E gene produced the enzyme phenotypically. [@B65] reported that occurrence of the *gel*E gene is not particularly linked to gelatinase production, since [@B60] suggest that other elements can be ascribed to *gel*E expression phenotypically. All *cyl*L gene-carrying isolates in this study expressed β-hemolytic activity. However, not all the isolates that phenotypically expressed the β-hemolytic activity harbored the *cyl*L gene. A contrasting situation was reported previously where some cytolysin gene-carrying isolates did not express β-hemolytic activity phenotypically ([@B29]; [@B95]).

Most enterococci strains from this study harbored the *esp* and *efa*A genes. Both genes appear to add to the persistence and colonization of enterococci in urinary tract infections (UTIs). The genes *ccf, cob*, and *cpd* (sex pheromone elements) were likewise detected in significant amounts of enterococci strains. Sex pheromone elements were identified solely in strains of *E. faecalis*, with all strains of *E. faecium* clear of the sex pheromone genes ([@B29]). This was not in agreement with our findings as a minimum of two out of the three sex pheromone elements were detected in all species tested and in line with the findings of [@B15]. Pheromone genes are occasionally followed with, and other times deprived of, the *agg* element ([@B29]). The S-layer and *ace* are surface proteins with adherence characteristics. The *ace* factor plays a significant role in enterococci establishment via adherence to the extracellular protein matrix. It also partakes in adhering type I and type IV collagen together ([@B73]). It has been reported in the literature via molecular methods that genes homologous to *efa*A occur in strains of *Enterococcus asini, Enterococcus avium, Enterococcus solitarius*, and *E. durans* ([@B87]; [@B50]).

The *esp* gene is situated on the pathogenicity island and similarly comprises proteins that are liable for the dynamics of antibiotic release ([@B58]). Literature reports on the *esp* protein established its involvement in biofilm and its role as a significant mechanism in exchanging genetic determinants inherently and elevating their antibiotic resistance characteristics ([@B32]; [@B57]). The occurrence of the *esp* gene in *E. faecium* has been reported to correlate imipenem, ampicillin, and ciprofloxacin resistance ([@B10]). Current reports propose a correlation of the occurrence of resistance to vancomycin and surface protein. [@B77] reported that nosocomial strains have revealed that 83.3% of vancomycin-resistant *E. faecium* were positive for the *esp* gene, which was similar to the findings of this study where all the enterococci isolates that were vancomycin resistant harbored the *esp* gene. Most of the enterococci that simultaneously harbored the *esp* genes with vancomycin resistance by [@B10] were multidrug resistant, which was also similar to the findings from our study. [@B76] reported that the *esp* element can be disseminated within strains of *E. faecalis* via the chromosome--chromosome transposition as well as within strains of *E. faecium* via conjugation of plasmid.

Hyaluronidase enzyme is crucial in breaking down mucopolysaccharides of the cartilage and connective tissue resulting in bacteria spread. The *hyl* element harboring isolates of nosocomial origin has been established to be frequent in *E. faecium* and rarely occurring in *E. faecalis* ([@B102]). In addition, the *hyl* determinant has also been detected in other *Enterococcus* species such as *E. durans, E. mundtii*, and *E. casseliflavus* recovered from food ([@B96]). The aggregation substance (*agg* gene) being a virulence factor conveys antibiotic resistance determinants ([@B16]). The aggregation substance encompasses diverse adhesins, coded on conjugative plasmids conveyed in an expedited conjugation pathway, intermediated by sex pheromones determinants ([@B91]). [@B23] described sex pheromones as small, non-water-loving peptides, which goes into aggregation substance and intermingle with a definite conjugative plasmid. The mechanism is essential in the dissemination of determinants among cells. Aggregation substance functions in the propagation within a particular plasmid, where factors encode virulence such as antibiotic resistance elements and cytolysin determinants. Cytolysin and aggregation elements can function together at the same time, elevating virulence by activating cytolysin regulation within the quorum-sensing pathway, thus conceivable to harm innermost tissues ([@B36]; [@B32]).

A significant factor in enterococci pathogenesis is the formation of biofilm. [@B25] reported that the higher amount of biofilm formed among *E. faecalis* compared to other *Enterococcus* species is not dependent on their source. Previous studies have reported that biofilm formation is not dependent on the presence or absence of the *esp* gene ([@B43]; [@B54]; [@B68]) while other researchers have stated clearly that there exists a positive correlation between biofilm formation and the occurrence of *esp* ([@B94]; [@B22]). [@B41] reported that gelatinase production/determinant has also been reported to mediate signals that arrive through the quorum-sensing *fsr* system leading to biofilm formation. [@B69] documented that no relationship exists between biofilm and gelatinase activity in a significant amount of *E. faecalis* isolates. Serine protease (*spr*E) encodes enzymes that hydrolyze peptide bonds in proteins, in which case serine serves as the nucleophilic amino acid at the active site. [@B68] stated that serine protease was more vital than gelatinase in biofilm production. Findings from our study revealed that the occurrence of *gel*E and *esp* elements was independent of biofilm formation, which was also in line with those of [@B15].

The most prevailing issue of enterococci includes resistance to antibiotics used as therapeutics in treating human patients. This is of particular interest since 54 (91.5%) enterococci from this study were resistant to ≥1 antibiotics, with a total of 37 (62.7%) enterococci isolates being multidrug resistant. Multiple antibiotic resistances to ≥4 antibiotics were reported in enterococci from abattoir and aquaculture environs ([@B1]; [@B44]). The relatively high percentage of MDR enterococci recovery from RTE shrimps portrays them as an important reservoir of antibiotic resistance. Lack of antibiotic sensitivity to subclasses and classes of antibiotics such as quinolones and fluoroquinolones could result in difficulty in handling enterococci infections. Isolates recovered from RTE shrimp samples in this study resisted ciprofloxacin (used in the treatment regimen of meningitis and pneumonia) and norfloxacin (used in the treatment regimen of UTI as well as in infections as a consequence of enterococci that resisted vancomycin with bacteremia inclusive). Resistance to quinolone antibiotics was observed solely in *E. faecalis, E. gallinarum*, and *E. faecium*. The proportion of quinolone-resistant enterococci recovered from RTE shrimp calls for concern, in view of the astonishing capacity of enterococci to disseminate resistance.

The highest frequency of resistance by [@B70] was observed for tetracycline (21.7%), followed by ciprofloxacin (2.0%), penicillin (2.0%), and ampicillin (1.0%), which were lower compared to our finding. *E. faecalis* revealed a higher prevalence of antibiotic resistance than other enterococci as described by [@B70], which was in line with the findings of this study. The percentage of MDR enterococci by [@B70] was 3.4%, which was lower than the findings of this study. An overall total of 54 (91.5%) isolates in our study that harbored a virulence gene were simultaneously resistant to a minimum of one antibiotic. All *E. durans, E. casseliflavus, E. hirae*, and *E. faecalis* in our study simultaneously harbor a virulent trait and were resistant to at least one antibiotic while 3 (10.4%) *E. faecium* and 2 (33.3%) *E. gallinarum* only harbor a virulent trait and completely sensitive to all antibiotics tried. This contradicts the study by [@B70] where *E. faecalis* 29 (26.6%), which carries one of the virulence-associated determinants, were simultaneously resistant to a minimum of one antibiotic. All enterococci strains screened for their antibiotic-resistant profiles revealed high multiresistance phenotype ([@B71]), which was contradicted by the findings from this study. Species-specific primers by [@B70] revealed *E. faecalis* as the predominant *Enterococcus* species carrying one or more virulence-associated determinants. Although all *E. faecalis* from this study harbored ≥3 virulence elements in this study, *E. faecium* was the most predominant of the *Enterococcus* species.

[@B11] reported that 16% of *E. faecalis* of sampled shrimp imported into Switzerland were resistant to tetracycline. A significant proportion of enterococci by [@B15] revealed that a significant proportion of the isolates were resistant to erythromycin (42.7%). Significant level of erythromycin resistance was also witnessed in this study. Enterococci are particularly resistant intrinsically ([@B20]). Intrinsic mechanisms usually result in decreased level of resistance while acquirement of mobile determinants particularly underscores a high level of resistance. The findings by [@B2] showed that *E. faecalis* from seafood possess multiple antibiotic resistances. These reports further consolidate the findings from this study. The dynamics and emergence of antimicrobial resistance determinants in bacteria that circulate between the environment, humans, and animals are not completely known. Selective pressure resulting from antimicrobials on the microbiomes of human and animal and their environments (particularly healthcare institutions and farms) as well as soil and sewage systems can likely confer persistence benefits on bacteria with antimicrobial resistance elements, which may further be spread via integrons, plasmids, or transposons ([@B18]).

Application of antibiotics as growth promoters is prohibited in Europe as far back as 2006. They are frequently applied in veterinary medicine for prophylactic purposes and as a treatment regimen. Antibiotics that are used as therapeutics for infections in humans might not be applied but can be important in the selection of resistant enterococci. Tetracyclines are usually applied as they are permitted by the Food and Drug Administration and the European Union for use in treating gastritis and hepatitis; diseases of the urinary, reproductive, and respiratory system; and bacterial infections that emanate from the skin ([@B67]). Tetracycline antibiotics are used in swine, cattle, poultry, sheep, fish, and goats ([@B5]). Its application in veterinary medicine has resulted in an upsurge in the number of antibiotic-resistant strains and selective pressure. It has also been documented that tetracycline-resistant enterococci usually portray combined resistance to aminoglycoside (gentamicin) and, to some extent, glycopeptide (vancomycin) ([@B19]). High occurrence of tetracycline resistance has previously been documented among enterococci strains from divergent sources ([@B93]; [@B17]). The occurrence of MDR enterococci isolates in the food chain is of a significant concern due to the ease of resistance gene dissemination to other bacteria. Enterococci have been described as a major concern in the last decades, as they have become one of the most vital nosocomial infections that cause serious illnesses in humans. The occurrence of *Enterococcus* spp. in seafood may act as gene pools of antibiotic resistance determinants ([@B100]). [@B15] reported that enterococci extensively occur in retail RTE meat or meat products with lots of enterococci strains such as *E. durans, E. casseliflavus, E. gallinarum*, and *E. hirae* harboring antibiotic resistance and conveying exchangeable resistance determinants.

Vancomycin-resistant enterococci (VRE) have been described as clinical pathogens that have been recovered from environmental habitats. The dissemination of opportunistic pathogens that harbor vancomycin-resistant genes further than hospital environments into the community is an impending public health threat as vancomycin is referred to as the last line of defense against enterococci infections. A total of 35 VRE outbreaks have been systematically reviewed and documented by [@B98], from which 757 patients were affected and 77 died; the prevalent site of pathogen recovery was rectal swabs or stool samples. The principal modes of documented spread were contact-to-contaminated environment, patient-to-patient, and hands of healthcare workers, while the predominant risk factor was previous antibiotic treatment regimen ([@B98]). The prevalent infection control procedures carried out by [@B98] were screening and isolation patient cohort. [@B90] reported a vancomycin variable *van*A+ enterococci outbreak that deviated from phenotypic expression via Clinical Laboratory Standards Institute guidelines and demonstrated the molecular machineries for switching *in vivo* into vancomycin resistance with lateral dissemination of the *van*A cluster. [@B86] revealed that genetic elements have an impact on resistance levels. A cluster of the silenced *van*A gene from patients on an exchangeable plasmid resulted in an outbreak of variable vancomycin enterococci ([@B90]).

[@B56] reported that genetic elements are frequently recovered from environmental isolates compared to food isolates. Genes that harbor resistance to tetracyclines in significant numbers of enterococci are confined to transposons frequently compared to plasmids ([@B15]). Such genes are sited on a transposon close to the *erm*B element, often considered as the prevalent determinant coding macrolide resistance. Erythromycin is an antibiotic that belongs to the macrolide class and used in the therapeutic regimen of infection in humans, particularly those with a documented allergic history to penicillin. The pattern of antibiotic resistance comprises disruption of the antibiotic passage into cells, which alters the target site of the antibiotic. The *erm*B gene is usually detected in enterococci strains recovered from clinical, environmental, and food sources and other Gram-positive cocci such as *Staphylococcus aureus* ([@B27]), *Streptococcus pyogenes* ([@B80]), or *Streptococcus pneumoniae* ([@B83]). Aside from the *erm*B gene, *E. faecalis* and *E. faecium* from food samples had a significant range of elements, which code for *N*-6 methyltransferase (*erm*C; *erm*A) or those accountable for the enterococci efflux characteristics (*mef*A/E; *msr*C). It has been described that *erm*A is frequently recovered in phenotypically macrolide-resistant *S. aureus* and other staphylococci ([@B105]).

Antibiotic usage must be firmly controlled to eradicate selective pressure, including regulating the application of antibiotic in veterinary practice and human medicine and incorporation of antibiotics as growth enhancers in animal feed. Increased attentiveness to infection control procedures to decrease the risk of obtaining resistant enterococci is crucial, particularly during institutionalization in healthcare facilities or antimicrobial use. The cycle of dissemination must be interjected through environmental cleaning, proper hand hygiene, avoidance of raw or undercooked food, and compliance with infection control procedures by healthcare personnel, patients, and visitors, specifically in the course of treatment with antibiotics. Furthermore, practical microbiological screening of patients hospitalized with associated risk factors for conveying resistant bacteria, as well as history of transfer from other hospitals, prolonged hospitalization, and transfer to endemic countries; directly pragmatic hand hygiene prior to intake of oral drugs, drinks, and food; and specific disinfection of mutual-touch or high-touch items, such as bed curtains and bed rails, are imperative. Final eradication and containment of the epidemic clones were attained by environmental decontamination using hydrogen peroxide vapor, absolute isolation deterrents, a vancomycin-resistant confinement ward, and antimicrobial stewardship ([@B33]).

Auto-inducing peptides have been reported to be part of the intercellular network in Gram-positive bacteria ([@B92]). Majority of these peptides are released via posttranslational modification in different ways and dedicated systems and are lastly sensed by other cells through receptors located in the membrane that are part of two-component regulatory systems. In this mechanism, the expression of different functions including genetic competence, virulence, and production of antimicrobials can be moderated in a coordinated cell-density- and growth-phase-dependent manner. Wide and indiscriminate application of antibiotics has led to serious ecological and biological concerns, particularly the development of antibiotic resistance. Probiotics are being suggested as an eco-friendly and effective substitute to antibiotics ([@B106]). Ethyl acetate and methanol root extract of *Anethum sowa* L. have been reported to show good antibacterial activity against *Enterococcus* species ([@B84]). *Enterococcus lactis* strain has been demonstrated to display bacteriocin-like activities against Gram-positive bacteria ([@B12]).

Conclusion
==========

This study revealed that *Enterococcus* species with biofilm potentials and extracellular virulence properties extensively occur in retail RTE shrimps. A significant number of isolated strains are resistant to antibiotics and harbor resistant and virulent genes, denoting a significant route of resistance and virulence dissemination to bacteria in humans. There is an inadequate understanding of the intricacies of antibiotic-resistant enterococci of food origin that belong to enterococci aside from *E. faecium* and *E. faecalis*. Findings from this study reveal detailed antibiotic resistance of *E. durans, E. casseliflavus, E. gallinarum*, and *E. hirae*. Finally, this study reveals that RTE seafood products are reservoirs of potential virulent enterococci with antibiotic-resistant capabilities that provide useful data for risk assessment and indicates that these foods may present a public health risk to consumers.
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